Attomarker constantly innovates and delivers

Gold Standard
Rapid Diagnostics

at the point-of-care

Suffering from Long Covid?

You can find out by booking an Attomarker Multi-Variant Antibody Immunity Spectrum (AMVAIS) Test

Attomarker believes that new challenges to our health require innovative answers inspired by rigorous science.

Listen to the CEO and Founder of Attomarker, Professor Shaw, on Dr Binita Kane’s Fireside Chat.

Rapid personalised diagnosis will enable earlier treatment designed to meet your unique, individual healthcare needs.

High quality diagnosis will reach beyond the laboratory and be accessible to everyone, in clinics, pharmacies and at home.

7 reasons